- Home
- PASG vs MIRA Comparison
PASG vs MIRA Comparison
Compare PASG & MIRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PASG
- MIRA
- Stock Information
- Founded
- PASG 2017
- MIRA 2020
- Country
- PASG United States
- MIRA United States
- Employees
- PASG N/A
- MIRA N/A
- Industry
- PASG Biotechnology: Pharmaceutical Preparations
- MIRA Biotechnology: Pharmaceutical Preparations
- Sector
- PASG Health Care
- MIRA Health Care
- Exchange
- PASG Nasdaq
- MIRA Nasdaq
- Market Cap
- PASG 27.6M
- MIRA 25.2M
- IPO Year
- PASG 2020
- MIRA 2023
- Fundamental
- Price
- PASG $8.68
- MIRA $1.29
- Analyst Decision
- PASG Strong Buy
- MIRA
- Analyst Count
- PASG 4
- MIRA 0
- Target Price
- PASG $59.25
- MIRA N/A
- AVG Volume (30 Days)
- PASG 34.4K
- MIRA 409.2K
- Earning Date
- PASG 11-12-2025
- MIRA 11-11-2025
- Dividend Yield
- PASG N/A
- MIRA N/A
- EPS Growth
- PASG N/A
- MIRA N/A
- EPS
- PASG N/A
- MIRA N/A
- Revenue
- PASG N/A
- MIRA N/A
- Revenue This Year
- PASG N/A
- MIRA N/A
- Revenue Next Year
- PASG N/A
- MIRA N/A
- P/E Ratio
- PASG N/A
- MIRA N/A
- Revenue Growth
- PASG N/A
- MIRA N/A
- 52 Week Low
- PASG $5.12
- MIRA $0.73
- 52 Week High
- PASG $26.60
- MIRA $2.56
- Technical
- Relative Strength Index (RSI)
- PASG 67.66
- MIRA 45.14
- Support Level
- PASG $8.00
- MIRA $1.28
- Resistance Level
- PASG $8.97
- MIRA $1.37
- Average True Range (ATR)
- PASG 0.48
- MIRA 0.05
- MACD
- PASG 0.04
- MIRA 0.00
- Stochastic Oscillator
- PASG 83.95
- MIRA 33.25
About PASG Passage Bio Inc.
Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease. The Company operates in a single reportable segment, developing and advancing genetic medicines designed to target critical underlying pathology of neurodegenerative diseases.
About MIRA MIRA Pharmaceuticals Inc.
Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.